Arcus Biosciences RCUS Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's deferred tax assets and other non-current assets?
- Arcus Biosciences (RCUS) reported deferred tax assets and other non-current assets of $61M in Q1 2026.
- How has Arcus Biosciences's deferred tax assets and other non-current assets changed year-over-year?
- Arcus Biosciences's deferred tax assets and other non-current assets decreased by 14.1% year-over-year, from $71M to $61M.
- What is the long-term trend for Arcus Biosciences's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Arcus Biosciences's deferred tax assets and other non-current assets has grown at a 58.8% compound annual growth rate (CAGR), from $6.25M to $63M.